miR-21 predicts poor prognosis in patients with osteosarcoma.

CONCLUSIONS: Upregulation of miR-21 was associated with poor clinicopathological characteristics. It is used as a marker of poor prognosis in patients with osteosarcoma. PMID: 27922432 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/27922432?dopt=Abstract

Source: British Journal of Biomedical Science - December 8, 2016 Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research